Focused Ultrasound for Targeted Drug Delivery in Huntington’s Disease
Author Information
Author(s): Helal Mohamed Mohsen, Ibrahim Arwa Amer, Beddor Ahmad, Kashbour Muataz
Primary Institution: Zagazig University
Hypothesis
Focused ultrasound can effectively deliver therapeutic agents across the blood-brain barrier to treat Huntington's disease.
Conclusion
Focused ultrasound shows promise as a non-invasive method to enhance drug delivery for Huntington's disease, improving therapeutic outcomes in preclinical models.
Supporting Evidence
- Focused ultrasound has been shown to safely open the blood-brain barrier in animal models.
- Preclinical studies indicate that focused ultrasound can enhance the delivery of neuroprotective agents.
- Focused ultrasound may improve motor function and reduce toxic protein aggregates in Huntington's disease models.
Takeaway
Focused ultrasound is like using a special sound to open a door in the brain that lets medicine in to help people with Huntington's disease.
Methodology
The review discusses preclinical studies using focused ultrasound to open the blood-brain barrier and deliver therapeutic agents in Huntington's disease models.
Limitations
The clinical application of focused ultrasound in Huntington's disease is still in early stages, with no completed trials specifically for HD patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website